전암 병변을 가진 부인과 환자의 처치

키워드

참고문헌 (88)

1. Cancer incidence in five continents, "Cancer incidence in five continents. Volume VIII", IARC Sci Publ, ~ (2002)
3. 2002년 한국중앙암등록사업 연례 보고서, "보건복지부", 보건복지부, ~ (2003)
4. 보건복지가족부, "보도자료: 2006~2007년 암발생률, 1993~2007년 암발생자의 생존율, 2007년 암유병률 통계 (2009년 12 월21일 발표)", ~
5. Melnikow J, "Natural history of cervical squamous intraepithelial lesions: a meta-analysis", Obstet Gynecol, 92, pp.727~735 (1998)
6. Ostor AG, "Natural history of cervical intraepithelial neoplasia: a critical review", Int J Gynecol Pathol, 12, pp.186~192 (1993)
7. Mitchell MF, "Cervical human papillomavirus infection and intraepithelial neoplasia: a review", J Natl Cancer Inst Monogr, 21, pp.17~25 (1996)
8. Wright TC Jr, "2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ", J Low Genit Tract Dis, 11, pp.223~239 (2007)
9. Addis IB, "Intraepithelial disease of the cervix, vagina, and vulva. In Berek & Novak's gynecology. 14th ed.", pp.561~600 (2007), Lippincott Williams & Wilkins
10. El-Bastawissi AY, "Effect of cervical carcinoma in situ and its management on pregnancy outcome", Obstet Gynecol, 93, pp.207~212 (1999)
11. Kyrgiou M, "The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach", Cancer Treat Rev, 32, pp.516~523 (2006)
12. Martin-Hirsch PL, "Surgery for cervical intraepithelial neoplasia", Cochrane Database Syst Rev, 2 (2000)
13. Nuovo J, "Treatment outcomes for squamous intraepithelial lesions", Int J Gynaecol Obstet, 68, pp.25~33 (2000)
14. Kalliala I, "Cancer free survival after CIN treatment: comparisons of treatment methods and histology", Gynecol Oncol, 105, pp.228~233 (2007)
15. Soutter WP, "Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia", Int J Cancer, 118, pp.2048~2055 (2006)
16. Kyrgiou M, "Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis", Lancet, 367, pp.489~498 (2006)
17. Samson SL, "The effect of loop electrosurgical excision procedure on future pregnancy outcome", Obstet Gynecol, 105, pp.325~332 (2005)
18. Sadler L, "Treatment for cervical intraepithelial neoplasia and risk of preterm delivery", JAMA, 291, pp.2100~2106 (2004)
19. Bruinsma F, "Precancerous changes in the cervix and risk of subsequent preterm birth", BJOG, 114, pp.70~80 (2007)
20. Jakobsson M, "Preterm delivery after surgical treatment for cervical intraepithelial neoplasia", Obstet Gynecol, 109, pp.309~313 (2007)
21. Bell MC, "Chemoprevention and vaccines: a review of the nonsurgical options for the treatment of cervical dysplasia", Int J Gynecol Cancer, 15, pp.4~12 (2005)
22. Stern PL, "Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination", J Clin Virol, 32(1), pp.~72 (2005), 81
23. Persad VL, "Management of cervical neoplasia: a 13-year experience with cryotherapy and laser", J Low Genit Tract Dis, 5, pp.199~203 (2001)
24. Ueda M, "Diagnostic and therapeutic laser conization for cervical intraepithelial neoplasia", Gynecol Oncol, 101, pp.143~146 (2006)
25. van Hamont D, "Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia", Int J Gynecol Cancer, 16, pp.615~619 (2006)
26. Wang SS, "Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000", Cancer, 100, pp.1035~1044 (2004)
27. Paraskevaidis E, "The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature", Cancer Treat Rev, 30, pp.205~211 (2004)
28. Zielinski GD, "HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis", Obstet Gynecol Surv, 59, pp.543~553 (2004)
29. Insinga RP, "Diagnoses and outcomes in cervical cancer screening: a population-based study", Am J Obstet Gynecol, 191, pp.105~113 (2004)
30. "SEER cancer statistics review 1975-2006"[URL]
31. Moscicki AB, "Regression of low-grade squamous intra-epithelial lesions in young women", Lancet, 364, pp.1678~1683 (2004)
32. Economos K, "Abnormal cervical cytology in pregnancy: a 17-year experience", Obstet Gynecol, 81, pp.915~918 (1993)
33. Yost NP, "Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions", Obstet Gynecol, 93, pp.359~362 (1999)
34. Robinson WR, "Degefu S, O'Quinn AG. Management of cervical intraepithelial neoplasia during pregnancy with LOOP excision", Gynecol Oncol, 64, pp.153~155 (1997)
35. Connor JP, "Noninvasive cervical cancer complicating pregnancy", Obstet Gynecol Clin North Am, 25(3), pp.1~42 (1998)
36. Paraskevaidis E, "Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum", Eur J Obstet Gynecol Reprod Biol, 104, pp.67~69 (2002)
37. Wright TC Jr, "American Society for Colposcopy and Cervical Pathology. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia", Am J Obstet Gynecol, 189, pp.295~304 (2003)
38. Stoler MH, "Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study", JAMA, 285, pp.1500~1505 (2001)
39. Clifford GM, "Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer", Cancer Epidemiol Biomarkers Prev, 14, pp.1157~1164 (2005)
40. Schlecht NF, "Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia", J Natl Cancer Inst, 95, pp.1336~1443 (2003)
41. Nobbenhuis MA, "Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear", Lancet, 358, pp.1782~1783 (2001)
42. Numnum TM, "A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?", J Low Genit Tract Dis, 9, pp.2~6 (2005)
43. Dunn TS, "A "see and treat" management for high-grade squamous intraepithelial lesion pap smears", J Low Genit Tract Dis, 7, pp.104~106 (2003)
44. Massad LS, "Biopsy correlates of abnormal cervical cytology classified using the Bethesda system", Gynecol Oncol, 82, pp.516~522 (2001)
45. Robertson AJ, "Observer variability in histopathological reporting of cervical biopsy specimens", J Clin Pathol, 42, pp.231~238 (1989)
46. Castle PE, "The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report", Am J Clin Pathol, 127, pp.805~815 (2007)
47. Wright TC Jr, "CHAPTER 3 Pathology of HPV infection at the cytologic and histologic levels: basis for a 2-tiered morphologic classification syste", Int J Gynaecol Obstet, 94(1), pp.22~31 (2006)
48. Park TW, "Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions", J Natl Cancer Inst, 88, pp.355~358 (1996)
49. Wright TC Jr, "Precancerous lesions of the cervix. In:Blaustein's pathology of the pemale genital tract. 5th ed.", pp.253~324 (2002), Springer-Verlag
50. Smith JS, "Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update", Int J Cancer, 121, pp.621~632 (2007)
51. Fine BA, "The pre- and postoperative value of endocervical curettage in the detection of cervical intraepithelial neoplasia and invasive cervical cancer", Gynecol Oncol, 71, pp.46~49 (1998)
52. Duggan BD, "Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study", Am J Obstet Gynecol, 180, pp.276~282 (1999)
53. Vedel P, "Five-year follow up of patients with cervical intra-epithelial neoplasia in the cone margins after conization", Eur J Obstet Gynecol Reprod Biol, 50, pp.71~77 (1993)
54. Gardeil F, "Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III", Obstet Gynecol, 89, pp.419~422 (1997)
55. Zaitoun AM, "Completeness of excision and follow up cytology in patients treated with loop excision biopsy", J Clin Pathol, 53, pp.191~196 (2000)
56. Felix JC, "The significance of positive margins in loop electrosurgical cone biopsies", Obstet Gynecol, 84, pp.996~1000 (1994)
57. Mohamed-Noor K, "Outcomes after cervical cold knife conization with complete and incomplete excision of abnormal epithelium: a review of 699 cases", Gynecol Oncol, 67, pp.34~38 (1997)
58. Paraskevaidis E, "Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia", Eur J Gynaecol Oncol, 24, pp.541~543 (2003)
59. Ørbo A, "Resection margins in conization as prognostic marker for relapse in high-grade dysplasia of the uterine cervix in northern Norway: a retrospective long-term follow-up material", Gynecol Oncol, 93, pp.479~483 (2004)
60. Reich O, "Cervical intraepithelial neoplasia III: long-term follow-up after cold-knife conization with involved margins", Obstet Gynecol, 99, pp.193~196 (2002)
61. Lapaquette TK, "Management of patients with positive margins after cervical conization", Obstet Gynecol, 82, pp.440~443 (1993)
62. Murdoch JB, "Histological incomplete excision of CIN after large loop excision of the transformation zone (LLETZ) merits careful follow up, not retreatment", Br J Obstet Gynaecol, 99, pp.990~993 (1992)
63. Andersen ES, "Adenocarcinoma in situ of the cervix: a prospective study of conization as definitive treatment", Gynecol Oncol, 86, pp.365~369 (2002)
64. Kennedy AW, "Further study of the management of cervical adenocarcinoma in situ", Gynecol Oncol, 86, pp.361~364 (2002)
65. Krivak TC, "Cervical adenocarcinoma in situ: a systematic review of therapeutic options and predictors of persistent or recurrent disease", Obstet Gynecol Surv, 56, pp.567~575 (2001)
66. Soutter WP, "Is conservative treatment for adenocarcinoma in situ of the cervix safe?", BJOG, 108, pp.1184~1189 (2001)
67. Azodi M, "Adenocarcinoma in situ of the cervix: management and outcome", Gynecol Oncol, 73, pp.348~353 (1999)
68. Lea JS, "Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ", Gynecol Oncol, 87, pp.129~132 (2002)
69. Hwang DM, "Long-term surveillance is required for all women treated for cervical adenocarcinoma in situ", J Low Genit Tract Dis, 8, pp.125~131 (2004)
70. Shin CH, "Conservative management of adenocarcinoma in situ of the cervix", Gynecol Oncol, 79, pp.6~10 (2000)
71. McHale MT, "Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix", Obstet Gynecol, 98, pp.726~731 (2001)
72. Kennedy CM, "New approaches to external genital warts and vulvar intraepithelial neoplasia", Clin Obstet Gynecol, 51, pp.518~526 (2008)
73. Howe HL, "Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends", J Natl Cancer Inst, 93, pp.824~842 (2001)
74. Holschneider CH, "Vulvar cancer. In:Berek & Novak's gynecology. 14th ed.", pp.1549~1580 (2007), Lippincott Williams & Wilkins
75. van Seters M, "Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients", Gynecol Oncol, 97, pp.645~651 (2005)
76. Todd RW, "Medical management of vulvar intraepithelial neoplasia", J Low Genit Tract Dis, 9, pp.206~212 (2005)
77. Wolcott HD, "Wide local excision in t e treatment of vulvar carcinoma in situ: a reappraisal", Am J Obstet Gynecol, 150, pp.695~698 (1984)
78. Modesitt SC, "Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence", Obstet Gynecol, 92, pp.962~966 (1998)
79. Stanley M, "Chapter 17: Genital human papillomavirus infections--current and prospective therapies", J Natl Cancer Inst Monogr, 31, pp.117~124 (2003)
80. Centers for Disease Control and Prevention, "Sexually transmitted diseases treatment guidelines, 2006", MMWR Recomm Rep, 55, pp.1~94 (2006)
81. Edwards L, "Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus", Arch Dermatol, 134, pp.25~30 (1998)
82. Megyeri K, "Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways", Mol Cell Biol, 15, pp.2207~2218 (1995)
83. Mayeaux EJ Jr, "Modern management of external genital warts", J Low Genit Tract Dis, 12, pp.185~192 (2008)
84. van Seters M, "Treatment of vulvar intraepithelial neoplasia with topical imiquimod", N Engl J Med, 358, pp.1465~1473 (2008)
85. Smith JS, "Human papillomavirus type: distribution in vulvar and vaginal cancers and their associated precursors", Obstet Gynecol, 113, pp.917~924 (2009)
86. Robinson JB, "Cavitational ultrasonic surgical aspiration for the treatment of vaginal intraepithelial neoplasia", Gynecol Oncol, 78, pp.235~241 (2000)
87. Hoffman MS, "Laser vaporization of grade 3 vaginal intraepithelial neoplasia", Am J Obstet Gynecol, 165, pp.1342~1344 (1991)
88. Kim HS, "Risk factors for recurrence of vaginal intraepithelial neoplasia in the vaginal vault after laser vaporization", Lasers Surg Med, 41, pp.196~202 (2009)

관련 논문AI추천